Back to Trades
Glessner Coleen
EVPQuality & Ethicsand CPLCIK 0001919170
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Glessner Coleen, EVP, Quality & Ethics, and CPL, has disclosed $1.1M in transactions — all concentrated in Emergent BioSolutions Inc. (EBS). Their disclosed trades are heavily weighted toward selling — $0 in buys and $306.1K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jun 10 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Tax withheld | $16.1K |
| May 1 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Grant | $0 |
| Mar 5 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Award | $472.3K |
| Feb 10 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Tax withheld | $346.2K |
| Oct 16 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | $306.1K |
5 filings